Safety Tips
- Meet in a safe, public place
- Check the item before buying
- Pay only after collecting the item
Description
Trodelvy (sacituzumab govitecan) is an advanced therapy for certain triple-negative breast cancer patients. Trodelvy suppliers in India cannot sell it for routine use as it is not yet approved in India by the CDSCO (Central Drugs Standard Control Organization) for marketing. Access to this medicine is possible only through authorized legal import channels on a case-by-case basis, such as the Named Patient Program, using a valid prescription and applicable import permits (Form 12A/12B). Indian Pharma Network (IPN) supports hospitals, doctors, and patients in following these regulatory procedures—coordinating documentation, permissions, and logistics to source Trodelvy from verified international suppliers, ensuring full compliance with applicable laws. Kindly call/WhatsApp: +91-9310090915 to learn more about the legal access process for Trodelvy in India.
Location
Noida, Uttar Pradesh